Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 93

    AstraZeneca scores win in race to treat ovarian cancer

    AstraZeneca scores win in race to treat ovarian cancer

    Medical Dialogues Bureau19 Aug 2019 3:45 PM IST
    Astra said its Lynparza drug, which blocks cancer's ability to repair its genetic code during cell division, was shown to slow the progression of...
    Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy

    Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy

    Medical Dialogues Bureau19 Aug 2019 3:43 PM IST
    Harmony Biosciences, LLC (Harmony) announced that the U.S. Food and Drug Administration (FDA) approved WAKIX (pitolisant) for the treatment of...
    Cipla shareholders approve raising up to Rs 3,000 cr

    Cipla shareholders approve raising up to Rs 3,000 cr

    Medical Dialogues Bureau19 Aug 2019 3:34 PM IST
    New Delhi: Indian Drug major Cipla on Saturday said its shareholders have approved a proposal to raise up to Rs 3,000 crore through issuance of...
    Edwards Lifesciences, Medtronic heart valves win U.S. approval for expanded use in TAVR

    Edwards Lifesciences, Medtronic heart valves win U.S. approval for expanded use in TAVR

    Medical Dialogues Bureau19 Aug 2019 2:09 PM IST
    Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition that restricts blood flow from the...
    Novartis exec sold shares before drug data manipulation made public

    Novartis exec sold shares before drug data manipulation made public

    Medical Dialogues Bureau19 Aug 2019 9:06 AM IST
    VIENNA: An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug...
    Sun Pharma collaborates with CMS to develop, commercialize 7 generic products in China

    Sun Pharma collaborates with CMS to develop, commercialize 7 generic products in China

    Medical Dialogues Bureau18 Aug 2019 10:00 AM IST
    "One of the company's wholly-owned subsidiaries has granted an exclusive license to a subsidiary of CMS to develop and commercialize seven generic...
    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Farhat Nasim18 Aug 2019 9:46 AM IST
    Hydrocortisone Valerate cream is a generic version of Sun Pharmaceutical Industries Ltd's Westcort cream in the same strength, Lupin added.New Delhi:...
    AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year

    AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year

    Medical Dialogues Bureau18 Aug 2019 9:36 AM IST
    A four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
    Domestic Pharma sales bounce back after two months of decline: Bloomberg

    Domestic Pharma sales bounce back after two months of decline: Bloomberg

    Medical Dialogues Bureau18 Aug 2019 9:35 AM IST
    48 out of 50 companies showed “positive growth” in India’s pharmaceutical market for the month of July, AIOCD-AWACS data showed. Among the top 10...
    Wockhardt Q1 net loss shrinks to Rs 45 crore from previous fiscal loss of Rs 89.18 crore

    Wockhardt Q1 net loss shrinks to Rs 45 crore from previous fiscal loss of Rs 89.18 crore

    Medical Dialogues Bureau18 Aug 2019 9:30 AM IST
    Total income of the company stood at Rs 871.19 crore during the quarter under review, down 14.18 per cent, from Rs 1,015.14 crore reported in the...
    GE Healthcare, Macquarie Medical Imaging, others collaborate to improve brain aneurysms diagnoses with AI

    GE Healthcare, Macquarie Medical Imaging, others collaborate to improve brain aneurysms diagnoses with AI

    Medical Dialogues Bureau18 Aug 2019 9:00 AM IST
    GE Healthcare will contribute through its leading medical imaging technology. Macquarie University and Macquarie Medical Imaging will provide clinical...
    Sun Pharma, CSIR-IICT ink licensing pact worth Rs 240 crore for patents

    Sun Pharma, CSIR-IICT ink licensing pact worth Rs 240 crore for patents

    Medical Dialogues Bureau17 Aug 2019 10:00 AM IST
    Sun Pharma will pay CSIR-IICT upfront and potential development, regulatory and sales milestone payments totalling up to Rs 240 crore plus royalties...
    PrevNext

    Popular Stories

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    China offers tariff exemptions on US medical equipment amid virus outbreak

    China offers tariff exemptions on US medical equipment amid virus outbreak

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok